No registrations found.
ID
Source
Health condition
Achillestendinopathy
Achillestendinopathie
Mid portion Achillestendinopathy
Mid portion Achillestendinopathie
Exercise therapy
Oefentherapie
Eccentric exercise
Excentrische oefeningen
Isometric exercise
Isometrische oefeningen
Pain
Pijn
Function
Functie
VISA-A score
Compliance
Therapietrouw
Sponsors and support
Intervention
Outcome measures
Primary outcome
Patient satisfaction
Functional outcome (VISA-A)
Secondary outcome
Pain relief after exercise during the first 4 weeks
Achievement of the treatment goal (defined by the patient)
Compliance
Patient Satisfaction
Background summary
not applicable
Study objective
Our hypothesis is that our gradually progressive protocol offers advantages with respect to the eccentric protocol based on the protocol of Alfredson (gold standard). We expect that, because this protocol is more individualized, less pain during the execution of the exercise program, therefore there is a better compliance and, and there is less chance of a deteriotaration of the tendon capacity (better clinical function).
Study design
0 weeks (T0; intake)
4 weeks (T1)
16 weeks (T2)
24 weeks (T3)
36 weeks (T4)
52 weeks (T5)
Intervention
1. tailor made, slowly progressive exercise program, guided by clincal parameters
2. standard eccentric exercise program;
M.A.W. Breuer
Veldhoven 5504 DB
The Netherlands
Tel. (040) 888 60 40
e-mail: m.breuer@mmc.nl
M.A.W. Breuer
Veldhoven 5504 DB
The Netherlands
Tel. (040) 888 60 40
e-mail: m.breuer@mmc.nl
Inclusion criteria
Age 18 years or older;
Clinical diagnosis (based on history and physical examination) of midportion Achillestendinopathy (the 2-7 cm proximal to the insertion on the calcaneus);
Duration of symptoms 3 months or more
Exclusion criteria
Insertional tendinopathy of the Achilles tendon;
Not able to carry out 'heavy load' eccentric exercises;
clinically suspected diagnosis of acute (partial) rupture of the Achilles tendon;
Surgical treatment of the affected Achilles tendon in the past;
Systemic disorders that seriously can influence the treatment/prognosis (diabetes mellitus, rheumatoid artritis).
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
NTR-new | NL5491 |
NTR-old | NTR5813 |
Other | METC MMC : W16.072 |